Physician profile
Gary Rocha
NPI 1447387907
$31,455.29
in general payments reported to CMS, 2019-2025
12 companies · $1,823 in 2025
The $1,823 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $5,451 · 2021: $622 · 2022: $2,090 · 2023: $1,199 · 2024: $1,690 · 2025: $1,823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,686 · Entertainment: $25.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,686.14 |
| Entertainment | $25.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $25,384.94 | 2019-2025 | Precision 1, Dailies Total1, Total30 |
| Coopervision INC. | $3,186.44 | 2020-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $825.69 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $682.60 | 2022-2025 | Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $479.81 | 2019-2021 | |
| Abb Con-Cise Optical Group LLC | $202.29 | 2019-2023 | Spectacle Lenses, Contact Lens |
| Glaukos Corporation | $161.31 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $159.58 | 2025 | Xdemvy |
| Menicon America INC | $128.59 | 2019-2020 | |
| Optos, INC. | $126.80 | 2019-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Allergan, INC. | $100.00 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Rocha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.